03 April 2025

Price inquiry SEMA 60/PR92443/2025 – conducted in the market research mode

In connection with the implementation of the project entitled “Development and development of an innovative solution – a generic drug from the group of GLP-1 receptor agonists in the treatment of type 2 diabetes” financed from the state budget by the Medical Research Agency, Polpharma S.A. Pharmaceutical Works is asking for tenders for the provision of services in the field of analytical research.

Details of the price inquiry can be found in the attached documents.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.